Fig. 6From: DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypesProposed scheme for combination biomarkers to stratify MIUC patients for chemo-immunotherapy. Tumor mRNA subtype, DDR mutation status and immunoregulatory gene expression levels should be included in one combination biomarker assay to select patients for chemo-immunotherapy. Image design by http://www.designsthatcell.ca/Back to article page